Related Experiment Video
Updated: Apr 18, 2026

11:03
High-resolution In Vivo Manual Segmentation Protocol for Human Hippocampal Subfields Using 3T Magnetic Resonance Imaging
Published on: November 10, 2015
10.1K
Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project
Simon Duchesne1, Fernando Valdivia1, Nicolas Robitaille1
1Department of Radiology, Université Laval and Centre de Recherche de l'Institut universitaire en santé mentale de Québec, Quebec City, Canada.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|January 25, 2015
Summary
A new platform standardizes hippocampal segmentation for Alzheimer's disease (AD) research. Training tracers on magnetic resonance imaging (MRI) improved their accuracy, enabling reliable hippocampal volumetry as an AD biomarker.
Area of Science:
- Neuroimaging
- Biomarker Development
- Alzheimer's Disease Research
Background:
- Hippocampal volumetry is crucial for Alzheimer's disease (AD) biomarker development.
- Standardized segmentation methods are required for reliable hippocampal volume measurements across different laboratories.
- The European Alzheimer's Disease Consortium and Alzheimer's Disease Neuroimaging Initiative (EADC-ADNI) Harmonized Protocol (HarP) provides a standardized method.
Purpose of the Study:
- To present a platform for training and qualifying tracers for manual hippocampal segmentation.
- To demonstrate that the platform's training process enhances compliance with the HarP.
- To establish a standardized method for evaluating tracer performance in hippocampal volumetry.
Main Methods:
- Thirteen tracers performed manual hippocampal segmentation on MRI scans.
- Segmentations were evaluated against benchmark images using volume, Jaccard similarity index, and spatial distance.
- Three training phases with visual feedback were followed by a qualification phase on new MRI scans.
Main Results:
- Statistical analysis showed a significant increase in Jaccard overlap (P < .001) between training phases for all tracers.
- The training process demonstrably improved tracer compliance with the HarP.
- Defined qualification thresholds were successfully met by all tracers.
Conclusions:
- The developed platform provides a robust infrastructure for standardized training and evaluation of tracers.
- This standardization is essential for the reliable use of hippocampal volumetry as an AD biomarker.
- The platform supports the integration of hippocampal volumetry in clinical and research settings for AD diagnosis and monitoring.

